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Abstract
Vitamin D is a secosteroid hormone 
that has expanding importance for a 
healthy lifestyle and disease prevention. A 
multitude of studies have highlighted that 
vitamin D acts not only in bone and 
calcium homeostasis but is critically 
important for human immunity. The 
discovery that the storage form of vitamin 
D (25-hydroxyvitamin D3) can be locally 
converted to the active form 
(1,25-hydroxyvitamin D3) in immune cells, 
epithelial cells and numerous other 
non-renal tissues highlights the importance 
of maintaining sufficient stores. When 
responding to a specific external stimulus, 
like bacterial invasion, intracrine synthesis 
of active vitamin D has the ability to 
regulate gene expression providing a 
specific response and directing cellular 
actions. These responses include the 
generation of antimicrobial peptides with 
production of these peptides dependent on 
vitamin D status. Vitamin D deficiency is 
associated with an increased rate of 
infection. This paper highlights the 
antibiotic like actions of vitamin D and 
importance of vitamin D sufficiency.
Introduction
Vitamin D can be obtained 
through diet in the form of D2 
(ergocalciferol, plant form) or D3 
(cholecalciferol, animal form) with 
D3 more efficiently converted to the 
storage form 25-hydroxyvitamin 
D3 or 25(OH)D. Unfortunately, diet 
provides very little of this necessary 
nutrient with approximately 80-90% 
of vitamin D3 made endogenously 
in the epidermis after exposure to 
the UVB rays in sunlight.1 Due to 
West Virginia’s location, from mid-
October to mid-March negligible 
vitamin D is produced through 
cutaneous synthesis due to the 
decrease in atmosphere penetration 
of UVB rays. Whether cutaneously 
produced or injected, vitamin D3 is 
bound to Vitamin D Binding Protein 
(VDBP) and circulated throughout 
the body.2 Once vitamin D3 reaches 
the liver, hydroxylation by CYP27A1 
occurs to form 25(OH)D which 
is the major circulating form and 
best indicator of vitamin D status. 
Sufficiency is defined as > 30ng/
ml.1,2,4 A second enzyme, CYP27B1, 
is found in over 30 cell types and 
acts to further metabolize 25(OH)
D to form the locally produced 
intracrine 1,25(OH)2D3 which is 
the active form of vitamin D.1,3,4 
Unlike the intracrine mechanism, 
the endocrine mechanism of vitamin 
D activation is in the proximal 
convoluted tubules of the kidneys 
where CYP27B1 is directly regulated 
by calcium and indirectly by PTH, 
linking vitamin D to a role in calcium 
homeostasis. Since its discovery, 
local production of active vitamin 
D has been shown to be important 
for optimal cellular functioning.
Vitamin D, Immunity and 
Toll-like Receptors
Active vitamin D has been shown 
to play a direct role in regulating 
transcription of approximately 
3% of the human genome in over 
30 different tissue types through 
vitamin D response elements (VDRE) 
on genes.2,5 Among its effects, 
vitamin D3 has been found to be an 
immune regulator with the ability 
to stimulate antimicrobial defense 
in epithelial barriers.6 Of note, 
antimicrobial actions of sunlight 
and vitamin D are not new concepts. 
In 1903, Dr. Niels Ryberg Finsen 
won the Nobel Prize for his work 
on the use of concentrated photo 
irradiation to cure lupus vulgaris, 
a cutaneous form of tuberculosis.7
Vitamin D’s role in innate 
immunity begins with toll-like 
receptors (TLRs). Found on many 
white blood cells, the ability 
of these receptors to recognize 
certain pathogen associated 
molecular patterns (PAMPs) 
such as lipopolysaccharides and 
flagella allows the body to respond 
to pathogens regardless of prior 
exposure. In the case of invading 
organisms such as M. tuberculosis, 
the TLR1 and TLR2 receptors 
on macrophages and monocytes 
recognize the bacterium and 
form a heterodimer. In addition 
to stimulating phagocytosis, the 
heterodimer induces the expression 
of CYP27B1 and vitamin D receptor 
(VDR). The resulting increase in local 
1,25(OH)2D3 and VDR expression 
creates an intracrine system that 
increases the oxidative burst 
potential of monocytes, recruits 
other immune cells to fight infection, 
and induces formation of natural 
antimicrobial peptides – most notably 
cathelicidins and human defensins.8
Vitamin D and Antimicrobial 
Peptide Production 
 Protection against assault from 
microbial pathogens involves a 
complex series of skin, mucosal 
surface and immune cell interactions 
that produce antimicrobial peptides 
and proteins in response to specific 
stimuli (see Figure 1, PAMP). In 
macrophages and monocytes, 
antimicrobial peptide production 
by the vitamin D intracrine 
system is best demonstrated by 
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the production of hCAP18, a 
cathelicidin antimicrobial peptide 
(CAMP) precusor that is cleaved 
to release LL37 (Figure 2). 
LL37 has many protective 
mechanisms. A largely cationic 
peptide, it can act as an antibiotic 
by disrupting the membranes of 
microbes through its interaction with 
their negatively charged capsular 
polysaccharides.10 It also protects 
against symptoms of infection by 
neutralizing the fever-producing 
endotoxin of gram negative bacteria.8 
By stimulating chemokine and 
cytokine production, LL37 can 
recruit other cells to participate in 
immune responses.10 Intracellularly, 
CAMP is able to stimulate autophagy 
which allows macrophages and 
monocytes to destroy intracellular 
organelles, proteins, or phagocytosed 
bacteria.11 This is particularly 
important when one considers M. 
tuberculosis persists in macrophages 
by preventing autophagy.7
 In addition to CAMP, 6 
α-defensins and 4 β-defensins with 
anti-microbial properties are also 
induced by the 1,25(OH)D intracrine 
system.8  These peptides can act 
synergistically with cathelicidin 
to disrupt microbial membranes 
and stimulate autophagy.11
Vitamin D, Immunity and 
Epithelial Barriers
Similar to macrophages and 
monocytes, vitamin D is closely 
tied to the immunological function 
of epithelial barriers such as the 
respiratory epithelium, skin, 
and placenta.10 In addition to 
strengthening the connections 
between the epithelial cells, vitamin 
D can stimulate the formation of 
antimicrobial peptides similar to 
those seen in macrophages and 
monocytes.8 In the lungs, normal 
human bronchial epithelial cells 
can be induced by 1,25(OH)D to 
produce CAMP. This is especially 
significant when considering 
populations who frequently 
experience respiratory infections.  
Cystic fibrosis patients, for example, 
may benefit from vitamin D-induced 
CAMP production to help combat 
infection by Pseudomonas aeruginosa.10
 Epithelial keratinocytes of 
damaged skin are also strong 
producers of CAMP.  Factors 
released from injured cells promote 
the formation of CYP27B1, leading 
to a local increase in 1,25(OH)D.  
This rise in active vitamin D levels 
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increases the keratinocyte expression 
of TLR2 and TLR4 which prepares 
the epithelium to react to potential 
pathogens.12 If TLR2 is activated, 
CAMP is produced by a mechanism 
similar to that of macrophages and 
monocytes and, LL37 stimulates 
keratinocyte migration and repair 
of damaged epithelium.10 
 Decidual and trophoblastic cells 
of the placenta constitutively express 
CYP27B1 to maintain a high level 
of 1,25(OH)D and therefore a high 
level of CAMP. This antibacterial 
environment could enhance the 
placenta’s function as a barrier to 
preempt fetal infection from microbes 
such as Listeria monocytogenes 
and Group B Streptococcus .12
Vitamin D Stores and 
Seasonal Immunity
Vitamin D may also contribute 
to the seasonality of infections. 
Influenza epidemics for example, 
long noted to occur during the 
winter months, were historically 
attributed to increased transference 
from populations collecting indoors 
to avoid the cold.13 However, this 
hypothesis could not explain a 
1977 study in which individuals 
given a live attenuated influenza 
vaccine in the winter were 8x more 
likely to display signs of infection 
than when given the same vaccine 
in the summer.14 In years since, 
extensive work has detailed the 
global absence of influenza epidemics 
during months with the greatest 
sunlight intensity.15 This has helped 
implicate sunlight and corresponding 
vitamin D levels as a contributor of 
influenza’s seasonality. As expected, 
vitamin D levels have been shown 
to be lowest during peak times of 
infection, and it is hypothesized 
that the decreased vitamin D 
levels lead to lower antimicrobial 
peptide and protein levels reducing 
one’s ability to combat infection.16 
Similarly, lower vitamin D levels 
could explain why individuals are 
more susceptible to live attenuated 
virus vaccines in the winter.
Like influenza, studies have 
also linked septicemia with UVB 
activated vitamin D. William Grant 
of the Sunlight, Nutrition and 
Health Research Center found that 
septicemia rates were highest in 
the winter and in the northeastern 
US, and were lowest in the summer 
and in the southwestern US – 
corresponding to the areas of low 
and high UVB levels respectively. 
Further supporting his conclusions, 
African Americans, who have 
decreased ability to activate vitamin 
D in the presence of UVB, were 
more likely than white Americans 
to get septicemia.17 More recent 
studies have elaborated on this 
connection by finding a high 
prevalence of decreased vitamin D 
binding protein levels in addition 
to vitamin D deficiency in patients 
with sepsis.18 Randomized controlled 
clinical trials are currently in 
progress to establish the effect 
of vitamin D supplementation 
on ICU septic patients.
Several studies have investigated 
vitamin D supplementation’s ability 
to prevent infection. One double 
blind trial of 208 women showed that 
no individuals reported an upper 
respiratory infection (URI)/influenza 
infection during the winter after 
receiving supplementation of 2,000 
IU of vitamin D daily for a year; <5% 
reported URI/influenza during the 
winter after taking 800 IU, and >20% 
reported URI/Influenza during the 
winter when given the placebo.19 
In a much more extensive study, a 
survey of 18,883 individuals 12 years 
and older showed that those with 
serum 25(OH)D levels of ≤10 ng/mL 
had 55% increased risk of  having a 
recent URI compared to those with a 
serum 25(OH)D level of ≥30 ng/mL.20 
In addition to preventing influenza, 
vitamin D therapy has been 
shown to modulate disseminated 
intravascular coagulation and 
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inflammatory cytokines in 
animal models of sepsis.18 
Vitamin D Sufficiency
The most plentiful and stable 
metabolite of vitamin D is 
25-hydroxyvitamin D and it is used 
as the primary indicator of vitamin 
D sufficiency (defined as 25(OH)
D > 30ng/mL).21,22,23 Safety research 
by the Mayo Clinic supports an 
upper limit of up to 10,000 IU of 
vitamin D3 daily with the National 
Academy of Sciences recommending 
an upper intake level of 4,000 
IU per day.22 Supplementation 
protocols for insufficiency are 
highlighted in reference 23.
Summary
Local production of active vitamin 
D is critical for human immunity. 
The apparent link between vitamin 
D stores and immunity comes 
from the ability of active vitamin 
D to induce several components 
of the innate immune system such 
as cathelicidin, defensins, and 
other genes that control oxidative 
burst potency. This link has been 
strengthened by discovering 
TLRs’ role in locally increasing 
active vitamin D levels to create an 
intracrine system. It is becoming 
apparent that vitamin D sufficiency 
is important in many facets of 
optimal human health and immunity 
including the impact of seasonal 
changes on communicable diseases.
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